Listed by the USPTO as FREHE, WILLIAM R
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 60% of resolved cases
FREHE, WILLIAM R has resolved 395 cases in Tech Center 3700 and Art Unit 3763. The allowance rate is 59.7%, and the median time to allowance is 1379 days. The 42.2% interview lift is the profile’s strongest prosecution signal, indicating that carefully prepared examiner engagement may be especially important when pursuing allowance in this docket.
The listed companies include Sanofi S.A., Shenzhen Shijiebao Trading Co. Ltd., and Willow Innovations Inc. The representative firms are Fideli Law PLLC, Bond, Schoeneck & King, PLLC - SANOFI, and Bayes PLLC. Counsel should pair interview planning with realistic expectations about the allowance rate and the extended median timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17057561 | Automatic Drug Delivery Device | Non-Final OA | Novartis AG |
| 16376738 | MINIMALLY INVASIVE SYSTEMS WITH EXPANDABLE SUPPORT AND PROXIMAL OPENING FOR HEMOSTASIS IN A BLEEDING CLOSED TISSUE VOLUME | Final Rejection | PROCEPT BioRobotics Corporation |
| 19275711 | Methods and Devices for Controlling Biologic Microenvironments | Final Rejection | P Tech, LLC |
| 18550650 | SOUND-DETECTION BASED INJECTION TIME MEASUREMENT SYSTEM FOR DRUG DELIVERY DEVICES | Non-Final OA | AMGEN INC. |
| 18667929 | INFUSION PUMP SYSTEM AND METHOD | Non-Final OA | Insulet Corporation |
| 18388372 | BREAST PUMP DEVICE | Final Rejection | SHENZHEN LUTE JIACHENG SUPPLY CHAIN MANAGEMENT CO., LTD. |
| 18636455 | Infusion Pump Assembly | Non-Final OA | DEKA Products Limited Partnership |
| 18288450 | Coded Housing Components for an Injection Device | Non-Final OA | Sanofi |
| 19022661 | Auto-Injector | Non-Final OA | Sanofi-Aventis Deutschland GMBH |
| 19022302 | Auto-Injector | Final Rejection | Sanofi-Aventis Deutschland GMBH |
| 19022613 | Auto-Injector | Non-Final OA | Sanofi-Aventis Deutschland GMBH |
| 18159719 | DRUG DELIVERY DEVICE | Final Rejection | Sanofi-Aventis Deutschland GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.7% of resolved applications examined by William R Frehe were allowed (395 resolved cases), compared with 60.3% across Art Unit 3763 over the last five years.
This examiner's interview lift is +42.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by William R Frehe took 1,379 days on average from filing to allowance.
William R Frehe examines applications in Art Unit 3763 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
